feed,title,long_url,short_url
ğŸ”MarketWatch,FDA approves Reataâ€™s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments,http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-71A5-89DF29346CDC%7D&siteid=rss&rss=1,https://da.gd/WsaEV6
ğŸ”MarketWatch,Crypto: Visa says crypto strategy unchanged after a report that itâ€™s pausing new partnership efforts,http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-71A5-7ED861FB9A96%7D&siteid=rss&rss=1,https://da.gd/WEx5d
ğŸ”MarketWatch,Earnings Results: Novavax stock shedding a quarter of its value as vaccine makerâ€™s business in â€˜substantial doubtâ€™,http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-71A6-2B350A73C5A5%7D&siteid=rss&rss=1,https://da.gd/xuIUhg
ğŸ”MarketWatch,PRO Act introduced for third time as lawmakers cite growing unionization push,http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-71A5-F6311D30E0A3%7D&siteid=rss&rss=1,https://da.gd/j9grL
